Malignant Anal Neoplasm — Trials

Malignant Anal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

254 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 68
Recruiting: 34
Ph III recruiting: 2
Growth YoY: —
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 27.1%
Trials / 1,000 deaths: 42.5 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07680088	Phase 2 Study of Pembrolizumab and Lenvatinib in Anal Squamous Cell Cancer	not yet recruiting	Phase 2	17	University of Texas Southwestern Medical CenterOTHER	0	Jul 2, 2026	clinicaltrials
NCT07668284	COQ10 and Vitamin E for Off-Target Radiation Toxicity	not yet recruiting	Phase 1 / Phase 2	200	University of NebraskaOTHER	1	Jun 25, 2026	clinicaltrials